Respiratory syncytial virus infection and bronchial hyperreactivity in children up to two years of age in correlation with atopy

Tijana Relić; Nevenka Ilić; Gordana Kostić; Dara Jovanović; Zoran Tambur; Ivana Lazarević

doi:10.2298/6840

Tijana Relić Public Health Institute of Belgrade, Belgrade, Serbia
Nevenka Ilić Public Health Institute of Kragujevac, Kragujevac, Serbia
Gordana Kostić Pediatric Clinic, Clinical Center Kragujevac, Kragujevac, Serbia
Dara Jovanović Public Health Institute of Belgrade, Belgrade, Serbia
Zoran Tambur Institute of Hygiene, Military Medical Academy, Belgrade, Serbia
Ivana Lazarević University of Belgrade, Faculty of Medicine, Institute of Microbiology and Immunology, Belgrade, Serbia

DOI: https://doi.org/10.2298/6840

Keywords: respiratory syncytial viruses, bronchial diseases, hypersensitivity, immediate, comorbidity, child, serbia,

Abstract

Background/Aim. Bronchiolitis in early childhood caused by respiratory syncytial virus (RSV) is considered to be important risk factor of the recurrent wheezing and asthma development. The aim of this study was to examine the frequency of RSV infection and atopy in children up to two years of age and to determine their correlation with bronchial hyperreactivity. Methods. The study included 175 children aged 5–24 months. The presence of RSV infection was identified by serum levels of IgA and IgG determined by ELISA. Bronchial hyperreactivity (BHR) has been defined as the existence of chronic bronchial disease and/or three or more previous suspected diagnosis of acute bronchial disease. Atopy was confirmed by detection of the specific serum IgE using quantitative multitest Phadiatop infant (cut off ≥ 0.35 kUA/L). Results. The children with atopy were more frequently infected with RSV (43.3%) than those without atopy (22.8%; p = 0.02). The higher frequency of RSV infection was found in children with BHR in comparison with those without it but only in the group who also had atopy (77.8% vs 28.6%, p = 0.018). In the female children, BHR and RSV infection were associated in 62.5% of cases, regardless the atopy. In the male children with atopy, RSV infection was associated with BHR in 83.3% of the cases, while in those without atopy, RSV infection with BHR was found in only 17.4% of the cases. Conclusion. Children up to two years of age with atopy are more frequently infected with RSV (43.3%) than non-atopic children. Every third child with atopy develops BHR and 77.8% of them also have RSV infection. Atopic children are at higher risk for development of BHR when infected with RSV also.

Author Biography

Zoran Tambur, Institute of Hygiene, Military Medical Academy, Belgrade, Serbia

naučni saradnik u VMA

References

Ogra PL. Respiratory syncytial virus: The virus, the disease and the immune response. Paediatr Respir Rev 2004; 5 Suppl A: S119−26.

Kimpen JL, Simoes EA. Respiratory syncytial virus and reactive airway disease. New developments prompt a new review. Am J Respir Crit Care Med 2001; 163(3 Pt 2): S1.

Meerhoff TJ, Fleming D, Smith A, Mosnier A, van Gageldonk-Lafeber B, Paget JW, et al. Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System. BMC Infect Dis 2006; 6(1): 128.

Pavlova S, Hadzhiolova T, Abadjieva P, Kotseva R. Application of RT-PCR for diagnosis of respiratory syncytial virus and human metapneumovirus infections in Bulgaria, 2006-7 and 2007-8. Euro Surveill 2009; 14(23): 19233.

Relić T, Ilić N, Đokić D, Kostić G, Veličković V, Jovanović D, et al. RSV infection in infants up to 2 years. Med čas 2011; 45(3): 9−15.

(Serbian)

Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J 2011; 18(2): 10−9.

Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 2008; 82(5): 2040−55.

Guilbert TW, Denlinger LC. Role of infection in the develop-ment and exacerbation of asthma. Expert Rev Respir Med 2010; 4(1): 71−83.

Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354(9178): 541−5.

Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk fac-tor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161(5): 1501−7.

Schauer U, Hoffjan S, Bittscheidt J, Köchling A, Hemmis S, Bongartz S, et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 2002; 20(5): 1277−83.

Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002; 109(2 Suppl): 362−7.

Živković Z. The incidence of asthma, rhinitis and eczema in children in Belgrade and Serbia. Deč Pulm 2002; 10(1−2): 27−43. (Serbian)

Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114(2): 239−47.

Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet J, Xatzipsalti M, et al. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 2007; 62(5): 457−70.

Bush A. How early do airway inflammation and remodeling occur. Allergol Int 2008; 57(1): 11−9.

Holt PG, Sly PD. Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med 2002; 196(10): 1271−5.

Mikalsen IB, Halvorsen T, Øymar K. The outcome after severe bronchiolitis is related to gender and virus. Pediatr Allergy Immunol 2012; 23(4): 391−8.

Halvorsen R, Jenner A, Hagelin EM, Borres MP. Phadiatop infant in the diagnosis of atopy in children with allergy-like symp-toms. Int J Pediatr 2009; 2009: 460737.

Kostić G. Quality of life in children with asthma before and after treatment with inhaled glucocorticoids. Kragujevac: Uni-versity of Kragujevac, Faculty of Medicine; 2009. (Serbian)

Gern JE, Rosenthal LA, Sorkness RL, Lemanske RF. Effects of vi-ral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 2005; 115(4): 668−74.

Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc Am Thorac Soc 2005; 2(2): 157−61.

Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection deter-mines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002; 196(10): 1381−6.

Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007; 195(8): 1126−36.

Kieninger E, Regamey N. Rhinoviruses: markers of, or causative for, recurrent wheeze and asthma. Eur Respir J 2012; 39(2): 238−9.

Jackson DJ, Lemanske RF. The role of respiratory virus infec-tions in childhood asthma inception. Immunol Allergy Clin North Am 2010; 30(4): 513−22.

Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitiza-tion, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119(5): 1105−10.

Høst A, Halken S. The role of allergy in childhood asthma. Al-lergy 2000; 55(7): 600−8.

Beigelman A, Bacharier LB. The role of early life viral bronchioli-tis in the inception of asthma. Curr Opin Allergy Clin Immunol 2013; 13(2): 211−6.

Chawes BL, Poorisrisak P, Johnston SL, Bisgaard H. Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants. J Allergy Clin Immunol 2012; 130(2): 354−61.

Thomsen SF, van der Sluis S, Stensballe LG, Posthuma D, Skytthe A, Kyvik KO, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009; 179(12): 1091−7.

Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Mar-tinez FD. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 2003; 111(4): 661−75.

Hibbert M, Lannigan A, Raven J, Landau L, Phelan P. Gender differences in lung growth. Pediatr Pulmonol 1995; 19(2): 129−34.

Wu P, Hartert TV. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther 2011; 9(9): 731−45.

Abbas AK, Lichtman AH, Pillai S. Mucosal immunity in the respiratory system. In: Abbas AK, Lichtman AH, Pillai S, editors. Cellular and molecular immunology. 7th ed. Philadelphia: Elsevier Saunders; 2012.

Corry DB, Kheradmand F, Luong A, Pandit L. Immunological mechanisms of airway diseases and pathways to therapy. In: Rich RR, editor. Clinical Immunology: principles and practice. 4th ed. Philadelphia: Elsevier Saunders; 2013.

Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ. Host-Pathogen Interactions in Campylobacter Infec-tions: the Host Perspective. Clin Microbiol Rev 2008; 21(3): 505−18.

Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitiza-tion, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119(5): 1105−10.